These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 17404858)

  • 1. Epidemiology, pathogenesis, and management of Clostridium difficile infection.
    Durai R
    Dig Dis Sci; 2007 Nov; 52(11):2958-62. PubMed ID: 17404858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of Clostridium difficile-associated disease.
    Leffler DA; Lamont JT
    Gastroenterology; 2009 May; 136(6):1899-912. PubMed ID: 19457418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Clostridium difficile infection in pediatric patients.
    Esposito S; Umbrello G; Castellazzi L; Principi N
    Expert Rev Gastroenterol Hepatol; 2015 Jun; 9(6):747-55. PubMed ID: 25912469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Feces culture successful therapy in Clostridium difficile diarrhea].
    Jorup-Rönström C; Håkanson A; Persson AK; Midtvedt T; Norin E
    Lakartidningen; 2006 Nov 15-21; 103(46):3603-5. PubMed ID: 17153868
    [No Abstract]   [Full Text] [Related]  

  • 5. Recent changes in Clostridium difficile infection.
    Silva Júnior M
    Einstein (Sao Paulo); 2012; 10(1):105-9. PubMed ID: 23045838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clostridium difficile-associated disease.
    Heins JR
    S D Med; 2006 Dec; 59(12):515-7. PubMed ID: 17212182
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pseudomembranous colitis: pathogenesis, prevention, treatment].
    Zakharova NV; Fil' TS
    Eksp Klin Gastroenterol; 2013; (12):87-91. PubMed ID: 24933996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A retrospective review of metronidazole and vancomycin in the management of Clostridium difficile infection in patients with hematologic malignancies.
    Parmar SR; Bhatt V; Yang J; Zhang Q; Schuster M
    J Oncol Pharm Pract; 2014 Jun; 20(3):172-82. PubMed ID: 23804627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clostridium difficile: an update for the primary care clinician.
    Salkind AR
    South Med J; 2010 Sep; 103(9):896-902. PubMed ID: 20697321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology, Diagnosis, and Management of Clostridium difficile Infection in Patients with Inflammatory Bowel Disease.
    Rao K; Higgins PD
    Inflamm Bowel Dis; 2016 Jul; 22(7):1744-54. PubMed ID: 27120571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fecal transplant via retention enema for refractory or recurrent Clostridium difficile infection.
    Kassam Z; Hundal R; Marshall JK; Lee CH
    Arch Intern Med; 2012 Jan; 172(2):191-3. PubMed ID: 22271132
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of recurrent and severe Clostridium difficile infection.
    Keller JJ; Kuijper EJ
    Annu Rev Med; 2015; 66():373-86. PubMed ID: 25587656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clostridium-difficile-associated diarrhea].
    Bujanda L; Cosme A
    Gastroenterol Hepatol; 2009 Jan; 32(1):48-56. PubMed ID: 19174100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clostridium difficile Infection: An Orthopaedic Surgeon's Guide to Epidemiology, Management, and Prevention.
    Anderson PA; Bernatz J; Safdar N
    J Am Acad Orthop Surg; 2017 Mar; 25(3):214-223. PubMed ID: 28134674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clostridium difficile in the long-term care setting.
    Makris AT; Gelone S
    J Am Med Dir Assoc; 2007 Jun; 8(5):290-9. PubMed ID: 17570307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Outcomes of Clostridium difficile enterocolitis after administration of antibiotics along with probiotic supplement].
    Doder R; Kovacević N; Munćan D; Potkonjak A; Tomasev B; Ruzić M
    Med Pregl; 2013; 66(5-6):209-13. PubMed ID: 23888728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of Clostridium difficile Infection With Probiotics.
    Evans CT; Johnson S
    Clin Infect Dis; 2015 May; 60 Suppl 2():S122-8. PubMed ID: 25922397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Typing and susceptibility of bacterial isolates from the fidaxomicin (OPT-80) phase II study for C. difficile infection.
    Citron DM; Babakhani F; Goldstein EJ; Nagaro K; Sambol S; Sears P; Shue YK; Gerding DN
    Anaerobe; 2009 Dec; 15(6):234-6. PubMed ID: 19755166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The search for a better treatment for recurrent Clostridium difficile disease: use of high-dose vancomycin combined with Saccharomyces boulardii.
    Surawicz CM; McFarland LV; Greenberg RN; Rubin M; Fekety R; Mulligan ME; Garcia RJ; Brandmarker S; Bowen K; Borjal D; Elmer GW
    Clin Infect Dis; 2000 Oct; 31(4):1012-7. PubMed ID: 11049785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The changing face of Clostridium difficile: what treatment options remain?
    Shen EP; Surawicz CM
    Am J Gastroenterol; 2007 Dec; 102(12):2789-92. PubMed ID: 18042108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.